SOLID FORMS OF N-(7-AZABICYCLO[2,2,1]HEPTAN-7-YL-)-2-(TRIFLUOROMETHYL)PHENYL)-4-OXO-5-(TRIFLUOROMETHYL)-1,4-DIHYDROQUIINOLINE-3-CARBOXAMIDE Russian patent published in 2014 - IPC C07D401/12 A61K31/4709 A61P1/18 A61P11/00 A61P27/00 

Abstract RU 2518479 C2

FIELD: chemistry.

SUBSTANCE: invention relates to form A of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl-)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide, where said form A is characterised by peak at approximately 7.9 degree, peak at approximately 11.9 degree, peak at approximately 14.4 degree and peak at approximately 15.8 degree in powder X-ray. Invention also relates to pharmaceutical composition and set based on said form A, application of form A, method of CFTR modulation.

EFFECT: obtained is novel form of quinoline derivative, which is modulator of CFTR activity.

12 cl, 3 dwg, 2 tbl, 3 ex

Similar patents RU2518479C2

Title Year Author Number
SOLID FORMS OF N-(4-(7-AZABICYCLO[2,2,1]HEPTAN-7-YL)-2-(TRIFLUOROMETHYL)PHENYL)-4-OXO-5-(TRIFLUOROMETHYL)-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE 2010
  • Chzhan Behjli
  • Kravets Mariush
  • Luizi Brajan
  • Medek Ales
RU2568608C2
METHOD FOR OBTAINING MODULATORS OF CYSTIC FIBROUSIS TRANSMEMBRANE CONDUCTANCE REGULATOR 2010
  • Ambkhaikar Narendra Bkhalchandra
  • Kh'Juz Robert
  • Kharli Dennis Dzhejms
  • Li Ehlejn Chungmin
  • Littler Bendzhamin
  • Numa Mekhdi
  • Reper Shtefani
  • Shet Urvi
RU2553989C2
SOLID FORMS OF (R)-1-(2,2-DIFLUOROBENZO[d][1,3]DIOXOL-5-YL)-N-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL)CYCLOPROPANE CARBOXAMIDE 2011
  • Keskhavarz-Skhokri Ali
  • Chzhan Behjli
  • Alkasio Tim Ehdvard
  • Li Ehlejn Chungmin
  • Chzhan Juehgan
  • Kravets Mariush
RU2573830C2
NEW TREATMENT 2015
  • Ebbott-Banner Ketarin
  • Khanrakhan Dzhon
  • Tomas Devid
RU2688191C2
SOLID FORMS OF 3-(2, 2-DIFLUOROBENZO[D][1,3] DIOXOL-5-YL)CYCLOPROPANCARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID 2011
  • Keskhavarz-Skhokri Ali
  • Chzhan Bejli
  • Kravets Mariush
RU2579370C2
PHARMACEUTICAL COMPOSITIONS CONTAINING 3-(2, 2-DIFLUOROBENZO[d][1, 3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDINE-2-YL)BENZOIC ACID, AND ADMINISTRATION THEREOF 2011
  • Vervejs Marinus Yakobus
  • Alargova Rossitsa Georgieva
  • Kaushik Ritu Rokhit
  • Kadiyala Irina Nikolaevna
  • Yang Kristofer Rajan
RU2592368C2
3-CARBOXAMIDE-4-OXOQUINOLINE DERIVATIVES, USEFUL AS MODULATORS OF REGULATOR OF TRANSMEMBRANE CYSTIC FIBROSIS CONDUCTIVITY 2010
  • Jang Sjaotsin
  • Adida Rua Sara S.
  • Grotenkhejs Peter D. J.
  • Van Gor Fredrik F
  • Botfild Martin K.
  • Zlokarnik Gregor
RU2518897C2
PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES MEDIATED BY A TRANSMEMBRANE REGULATOR OF CYSTIC FIBROSIS (CFTR) 2013
  • Vervejs Marinus Yakobus
  • Karkare Radkhika
  • Mur Majkl Duglas
RU2692676C2
SILICON-CONTAINING IVACAFTOR ANALOGUES 2017
  • Munoz, Benito
  • Parks, Daniel
  • Bastos, Cecilia, M.
RU2796112C2
SOLID FORMS OF (R)-1-(2, 2-DIFLUOROBENZO[D][1, 3]DIOXOL-5-YL)-N-(1-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL) CYCLOPROPANECARBOXAMIDE 2011
  • Keskhavarz-Skhokri, Ali
  • Chzhan, Bejli
  • Alkasio, Tim, Edvard
  • Li, Elejn, Chungmin
  • Chzhan, Yuegan
  • Kravets, Mariush
RU2711481C2

RU 2 518 479 C2

Authors

Chzhan Behjli

Kravets Mariush

Botfild Martin

Grotenkhejs Peter D J.

Van Gur Fredrik

Dates

2014-06-10Published

2009-10-23Filed